These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 982436)

  • 1. Electroencephalograms in a case of maple syrup urine disease: their relation to serum levels of branched-chain amino acids.
    Iinuma K; Saito T; Wada Y; Onuma A; Takamatsu N
    Tohoku J Exp Med; 1976 Oct; 120(2):191-5. PubMed ID: 982436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of maple-syrup-urine disease for the first four days of life.
    DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M
    N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815
    [No Abstract]   [Full Text] [Related]  

  • 4. Semiquantitation of leucine, isoleucine, and valine by thin-layer chromatography in management of maple-syrup urine diseases.
    Allen RJ; Frey HJ; Fleming LM; Owings CL
    Clin Chem; 1972 May; 18(5):413-6. PubMed ID: 5019114
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
    Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI
    Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of branched-chain amino acid intake in children with maple syrup urine disease and methylmalonic aciduria.
    Parsons HG; Carter RJ; Unrath M; Snyder FF
    J Inherit Metab Dis; 1990; 13(2):125-36. PubMed ID: 2116544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of maple syrup urine disease by determination of L-valine, L-isoleucine, L-leucine and L-phenylalanine in neonatal blood spots by gas chromatography-mass spectrometry.
    Deng C; Deng Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(2):261-8. PubMed ID: 12860033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent branched chain ketonuria (variant of maple syrup urine disease).
    Irwin WC; Martel SB; Goluboff N
    Clin Biochem; 1971 Jun; 4(2):52-8. PubMed ID: 5128296
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic study of the classic form of leucinosis during exchange transfusion therapy].
    Zeman J; Hyánek J; Houstková H; Rubín A; Verner P; Pehal F; Konecná L; Zapadlo M; Plavka R; Wendel U
    Cesk Pediatr; 1987 Apr; 42(4):219-22. PubMed ID: 3594613
    [No Abstract]   [Full Text] [Related]  

  • 10. [Leucinosis: study of a case].
    Moura-Ribeiro MV; Funayama CA
    Arq Neuropsiquiatr; 1985 Dec; 43(4):403-6. PubMed ID: 3833142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acrodermatitis enteropathica-like syndrome secondary to branched-chain amino acid deficiency during treatment of maple syrup urine disease].
    Templier I; Reymond JL; Nguyen MA; Boujet C; Lantuejoul S; Beani JC; Leccia MT
    Ann Dermatol Venereol; 2006 Apr; 133(4):375-9. PubMed ID: 16733455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
    Kindt E; Halvorsen S
    Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maple syrup urine disease. Two cases in Israel.
    Chemke J; Levin S
    Isr J Med Sci; 1975 Aug; 11(8):809-16. PubMed ID: 1165176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maple syrup urine disease variant: report on an infant.
    Koepp P; Rybak C; Rüdiger HW; Wendel U
    Z Kinderheilkd; 1974 Feb; 116(3):177-84. PubMed ID: 4813457
    [No Abstract]   [Full Text] [Related]  

  • 15. An 11-day-old boy with lethargy, poor feeding, vomiting. Maple syrup urine disease.
    Charrow J
    Pediatr Ann; 2005 Oct; 34(10):772-4. PubMed ID: 16285630
    [No Abstract]   [Full Text] [Related]  

  • 16. Maple syrup urine disease (branched-chain keto-aciduria) variant type manifesting as hyperkinetic behaviour and mental retardation. Report of two cases.
    Kalyanaraman K; Chamukuttan S; Arjundas G; Gajanan N; Ramamurthi B
    J Neurol Sci; 1972 Feb; 15(2):209-17. PubMed ID: 5010106
    [No Abstract]   [Full Text] [Related]  

  • 17. [Maple syrup urine disease with an intermittent relatively benign course].
    Müller H; Bickel H; Feist D; Lutz P
    Dtsch Med Wochenschr; 1971 Oct; 96(40):1552-7. PubMed ID: 5093339
    [No Abstract]   [Full Text] [Related]  

  • 18. [Maple syrup urine disease. (Valine-leucine-uria)].
    Platt D; Beneke G; Peiffer J; Schmidt GW
    Med Welt; 1966 May; 19():1089-93. PubMed ID: 5974899
    [No Abstract]   [Full Text] [Related]  

  • 19. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation.
    Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE
    Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
    Snyderman SE; Goldstein F; Sansaricq C; Norton PM
    Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.